This message is automatically generated.
The header of a mail message being sent to you was damaged during transit,
so could not be delivered normally. The full message is included below.
Please ensure that addresses for replies to the email are entered manually,
as use of any reply option will send the reply to the wrong destination.
If the message was destined for a list it is likely that some members
of the list will have already received the message, so duplication may
ocurr.
We apologise for the delay in delivery and any inconvenience caused.
Please direct enquiries concerning this problem to
[log in to unmask]
Chris Bayliss
Information Services
The University of Birmingham
Original message follows
==========================================================================
Received: from naga.mailbase.ac.uk by bham.ac.uk with SMTP (PP); Mon, 7 Oct 1996 10:10:40 +0100
Received: by naga.mailbase.ac.uk id <[log in to unmask]>
(8.7.5/ for naga.mailbase.ac.uk); Mon, 7 Oct 1996 10:07:27 +0100 (BST)
Received: from planet.ak.planet.gen.nz by naga.mailbase.ac.uk id <[log in to unmask]>
(8.7.5/ for naga.mailbase.ac.uk) with ESMTP; Mon, 7 Oct 1996 10:07:22 +0100 (BST)
Received: from samcorp90 (ppp0-18.ak.planet.gen.nz [202.36.28.68]) by planet.ak.planet.gen.nz (8.7.3/8.7.3) with ESMTP id VAA08699 for <[log in to unmask]>; Mon, 7 Oct 1996 21:08:31 +1200 (NZST)
Message-Id: <[log in to unmask]>
From: "Jon Wilcox" <[log in to unmask]>
To: <[log in to unmask]>
Subject: Re: Treating raised lipids
Date: Mon, 7 Oct 1996 21:43:28 +1300
X-MSMail-Priority: Normal
X-Priority: 3
X-Mailer: Microsoft Internet Mail 4.70.1155
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary="----=_NextPart_000_01BBB498.93493DE0"
Content-Transfer-Encoding: 7bit
X-List: [log in to unmask]
X-Unsub: To leave, send text 'leave gp-uk'
to [log in to unmask]
Reply-To: [log in to unmask]
Sender: [log in to unmask]
Precedence: list
This is a multi-part message in MIME format.
------=_NextPart_000_01BBB498.93493DE0
Content-Type: text/plain; charset=ISO-8859-1
Content-Transfer-Encoding: 7bit
>I doubt whether any of the recent cholesterol studies have attempted to
look at
>the benefits of treating patients over the age of 70
>In the absence of this evidence there is a clear risk you may do more harm
than
>good in treating with statins in this age group
>Dr Amrit Takhar
>GP Cambs Uk
I am now confused. I am totally unaware of any documented (proven) risk
associated with statin use.
Perhaps someone can enlighten me.
There is most certainly risk with the fibrates.
Statins are statins and fibrates are fibrates.
Jon Wilcox
"Fantasyland"
------=_NextPart_000_01BBB498.93493DE0
Content-Type: text/html; charset=ISO-8859-1
Content-Transfer-Encoding: quoted-printable
<html><head></head><BODY bgcolor=3D"#FFFFFF"><p><font size=3D2 =
color=3D"#000000" face=3D"Arial">>I doubt whether any of the recent =
cholesterol studies have attempted to look at<br>>the benefits of =
treating patients over the age of 70<br><b><u>>In the absence of this =
evidence there is a clear risk you may do more harm than<br>>good in =
treating with statins in this age group<br></u></b><br>>Dr Amrit =
Takhar<br>>GP Cambs Uk<br><font size=3D2><br>I am now confused. I am =
totally unaware of any documented (proven) risk associated with statin =
use.<br>Perhaps someone can enlighten me.<br>There is most certainly =
risk with the fibrates.<br>Statins are statins and fibrates are =
fibrates.<br>Jon Wilcox<br>"Fantasyland"</p>
</font></font></body></html>
------=_NextPart_000_01BBB498.93493DE0--
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|